Combatting Flu Season with Bioteke's 8-in-1 Respiratory Multipathogen Antigen Rapid Test Kit

As flu season intensifies, accurate and rapid diagnosis of respiratory illnesses is more crucial than ever. Influenza viruses, along with other respiratory pathogens, are spreading at alarming rates globally, increasing the burden on healthcare systems. 

To address this urgent need, Bioteke Corporation(wuxi) Co., Ltd introduces its 8-in-1 Respiratory Multipathogen Antigen Rapid Test Kit—an effective rapid diagnostic-testing solution designed to simplify and accelerate pathogen detection. 

It provides efficient, convenient and accurate rapid antigen diagnosis tools for institutions that improve various medical services and commercial medical device service companies such as health care centers.

---

A Comprehensive Testing Solution

The 8-in-1 Respiratory Multipathogen Antigen Rapid Test Kit is a immunochromatographic and double-antibody sandwich menthod, for in vitro qualitative detection of 8 common human respiratory pathogens in one test, including SARS-CoV-2, influenza A, influenza B, Parainfluenza 1/2/3, respiratory syncytial virus (RSV), Adenovirus and Mycoplasma pneumoniae (MP) anitgen in human nasopharyngeal swab specimens.

KEY FEATURES:

• Rapid Results: Delivers accurate results within 15 minutes, allowing timely clinical decisions.

• Multi-Pathogen Detection: Reduces the need for multiple tests by identifying multiple pathogens from a single sample.

• Convenient Sampling: Compatible with nasal swabs, throat swabs for patient comfort and flexibility.

• High Sensitivity and Specificity: Ensures reliable detection even at low pathogen concentrations.

• Portable and User-Friendly: Ideal for use in clinics, medical service institutions and even mobile testing units, etc.

• Certification: It has passed IVD CE certification and has free sales certificates(FSC) in many countries and regions. 

---

Current Influenza Activity in the United States and Europe

In the United States, the Centers for Disease Control and Prevention (CDC) reports that, for the 2024-2025 flu season, there have been at least 1.9 million illnesses, 23,000 hospitalizations, and 970 deaths attributed to influenza so far. Notably, two pediatric deaths associated with seasonal influenza virus infection were reported in the latest week, bringing the season's total to four pediatric deaths¹._{(Data from the Centers for Disease Control and Prevention of the USA.)}

In Europe, the European Centre for Disease Prevention and Control (ECDC) estimates that up to 20% of the population are infected with seasonal influenza each year. Recent reports indicate that influenza activity has increased in parts of Europe, with influenza A(H1N1)pdm09 being the most detected subtype.

Why Early Diagnosis Matters

Timely identification of respiratory pathogens is critical to controlling the spread of infections, especially during flu season. Misdiagnosis or delays can lead to improper treatments, higher transmission rates, and additional strain on healthcare resources. 

With Bioteke's 8-in-1 kit, healthcare providers can make informed decisions quickly, ensuring appropriate treatment and isolation measures.

Meeting Global Needs

Bioteke's rapid test kit is designed with a global perspective. With flu seasons varying by hemisphere and the ever-present threat of new respiratory pathogens, this versatile diagnostic tool is indispensable. Backed by international certifications and compliant with rigorous standards, the kit is ready to serve in diverse healthcare settings worldwide.

Supporting Healthcare Professionals and Institutions

This test kit is not just a product—it's a comprehensive solution aimed at enhancing diagnostic capabilities, improving patient outcomes, and reducing the overall healthcare burden. For distributors, agents, wholesalers, clinics and medical service suppliers, etc. Bioteke offers tailored partnerships to ensure seamless integration of the 8-in-1 Respiratory Multipathogen Antigen Rapid Test Kit into their workflows.

Partner with Bioteke

As a trusted name in diagnostic solutions, Bioteke remains committed to innovation and excellence. Explore how our 8-in-1 Respiratory Multipathogen Antigen Rapid Test Kit can empower your healthcare operations this flu season.

Contact us today to learn more about our product offerings or to place an order. Let's work together to combat respiratory illnesses effectively and efficiently.

BioTeke Corporation(wuxi) Co., Ltd

Address: Zone A, 4F, No.1719-5, Huishan Avenue, Wuxi, Jiangsu 214174, China

E-mail(International Marketing): zr@bioteke.cn

Phone: +86 18115363743

References:

1.Weekly US Influenza Surveillance Report: Key Updates for Week 50, ending December 14, 2024.(CDC)

2. European Centre for Disease Prevention and Control.(ECDC)

3. Featured meeting report | 24 December 2024. Influenza Update N° 507(WHO)